Meeder Advisory Services’s Pfizer PFE Stock Holding History

Meeder Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.28M	Buy	116,700 +17,764	+18%	+$473K	0.14%	102
2025 Q4	$2.46M	Buy	98,936 +5,294	+6%	+$134K	0.11%	129
2025 Q3	$2.39M	Buy	93,642 +14,032	+18%	+$346K	0.11%	132
2025 Q2	$1.93M	Buy	79,610 +19,588	+33%	+$457K	0.1%	152
2025 Q1	$1.52M	Sell	60,022 -196	-0.3%	-$5.13K	0.09%	175
2024 Q4	$1.6M	Sell	60,218 -1,566	-3%	-$42.5K	0.1%	155
2024 Q3	$1.79M	Buy	61,784 +1,503	+2%	+$43.8K	0.12%	143
2024 Q2	$1.69M	Buy	60,281 +12,208	+25%	+$336K	0.12%	142
2024 Q1	$1.33M	Sell	48,073 -2,041	-4%	-$56.6K	0.14%	130
2023 Q4	$1.44M	Sell	50,114 -10,003	-17%	-$302K	0.17%	107
2023 Q3	$1.99M	Sell	60,117 -9,160	-13%	-$324K	0.25%	64
2023 Q2	$2.54M	Sell	69,277 -2,558	-4%	-$99.6K	0.27%	58
2023 Q1	$2.93M	Sell	71,835 -4,118	-5%	-$178K	0.34%	47
2022 Q4	$3.89M	Buy	+75,953	New	+$3.64M	0.49%	34

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Meeder Advisory Services's PFE Position: Q1 2026 in Review

Meeder Advisory Services increased its Pfizer (PFE) stake by 18% in Q1 2026, buying an estimated $473K and bringing the position to 116,700 shares worth $3.28M. The position accounts for 0.14% of the portfolio, ranked #102.

Meeder Advisory Services first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.89M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Meeder Advisory Services held 116,700 shares of Pfizer worth $3.28M as of Q1 2026.
Meeder Advisory Services bought 17,764 Pfizer shares in Q1 2026, an estimated $473K.
Pfizer made up 0.14% of Meeder Advisory Services's portfolio in Q1 2026, its #102 holding.
Meeder Advisory Services first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
Meeder Advisory Services's Pfizer position peaked at $3.89M in Q4 2022.
2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.